GoodRx Holdings (GDRX) Long-Term Investments (2020)

GoodRx Holdings (GDRX) posted Long-Term Investments of $711.4 million for Q4 2020.

GoodRx Holdings (GDRX) Long-Term Investments (2020) Analysis & Trends

GoodRx Holdings has reported Long-Term Investments for 1 years, with the latest figure at $711.4 million in Q4 2020.

  • Quarterly Long-Term Investments changed N/A year-over-year to $711.4 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $711.4 million (changed N/A YoY) and the FY2020 annual result came in at $711.4 million, changed N/A from the prior year.
  • Long-Term Investments held at $711.4 million in Q4 2020 per GDRX's latest filing.
  • Over five years, Long-Term Investments peaked at $711.4 million in Q4 2020 and troughed at $711.4 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 7.54 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn -
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn -
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn 84.74 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn -
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn 84.29 Mn
10 GoodRx Holdings 1.27 Bn 972.56 Mn 179.41 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 711.38 Mn